Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed)
The summary for the Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed): This Funding Opportunity Announcement (FOA) solicits Phase I (R41), Phase II (R42), and Fast-track (R42) Small Business Technology Transfer (STTR) grant applications from small business concerns (SBCs) in collaboration with environmental science researchers to develop novel tools, activities, or materials to build environmental health literacy for a variety of groups, including community members, health care and public health professionals, educators, and students of all ages.
Federal Grant Title: | Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Environment Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-ES-21-009 |
Type of Funding: | Grant |
CFDA Numbers: | 93.113 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | November 10th, 2021 |
Original Application Deadline: | November 10th, 2021 |
Posted Date: | August 12th, 2021 |
Creation Date: | August 12th, 2021 |
Archive Date: | December 16th, 2021 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | August 12th, 2021 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-21-009.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires. - Similar Government Grants
- • Administrative Supplements to Promote Diversity in Research and Development Small Business...
- • Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical ...
- • Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoct...
- • Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoct...
- • Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoct...
- • Outstanding New Environmental Scientist Award (ONES)
- • Environmental Health Sciences Core Center Grants
- • Leiomyomata Uteri: Basic Science and Translational Research
- More Grants from the National Institutes of Health
- • Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)
- • Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-...
- • Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials o...
- • Administrative Supplements to Promote Diversity in Research and Development Small Business...
- • Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial...